OpportunityTitle: Standardizing Electronic Laboratory and Biomarker Reporting
AdditionalInformationOnEligibility: &#149;American Indian/Alaska Native tribal governments (federally recognized or state-recognized)  &#149;American Indian/Alaska native tribally designated organizations  &#149;Alaska Native health corporations  &#149;Colleges  &#149;Community-based organizations  &#149;Faith-based organizations  &#149;For-profit organizations (other than small business)  &#149;Hospitals  &#149;Nonprofit with 501C3 IRS status (other than institution of higher education)  &#149;Nonprofit without 501C3 IRS status (other than institution of higher education)  &#149;Political subdivisions of States (in consultation with States)  &#149;Research institutions (that will perform activities deemed as non-research)  &#149;Small, minority, and women-owned businesses  &#149;State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau).   &#149;Tribal epidemiology centers  &#149;Universities  &#149;Urban Indian health organizations  A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a legal, binding agreement from the state or local government as documentation of the status is required.
Description: This FOA emphasizes the importance of coordination and collaboration across agencies, partners, and organizations to improve standardized electronic reporting of laboratory data to central cancer registries for use in cancer surveillance. Specifically, this opportunity will; &#149;facilitate development of standards for electronic reporting to central cancer registries from clinical and anatomic laboratories, &#149;identify and document the barriers and solutions to accurately capture data contained in biomarker/molecular tests &#149;Promote expansion of electronic reporting from laboratories to central cancer registries.
GrantorContactEmailDescription: Technical Information Management Section (TIMS)
GrantorContactText: CDC Procurement and Grants Office (PGO)  &lt;br/&gt;Technical Information Management Section (TIMS) &lt;br/&gt;Phone: 770-488-2700 &lt;br/&gt;
CloseDateExplanation: Dates:  Optional Letter of Intent Deadline Date: May 20, 2013 11:59 p.m. U.S. Eastern Standard   Time    Application Deadline Date: June 17, 2013, 11:59 p.m. U.S. Eastern Standard Time